【正文】 QT綜合征，有頻發(fā)或復(fù)雜室性異位活動(dòng)但不伴持續(xù)性 VT III 類適應(yīng)證 : 起搏預(yù)防和終止心動(dòng)過(guò)速 (起搏預(yù)防心動(dòng)過(guò)速 ) Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at Section IF: 頸動(dòng)脈過(guò)敏綜合征及神經(jīng)心臟性暈厥的起搏治療 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at I 類適應(yīng)證 : 頸動(dòng)脈竇過(guò)敏和神經(jīng)心臟性暈厥的起搏治療 ；在未用任何抑制竇房結(jié)或房室傳導(dǎo)藥物的前提下，輕微按壓頸動(dòng)脈導(dǎo)致 3 s的心室停搏 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at IIa 類適應(yīng)證 : 頸動(dòng)脈竇過(guò)敏和神經(jīng)心臟性暈厥的起搏治療 ，伴有頸動(dòng)脈竇高敏性心臟抑制反射 ，記錄或 TTT時(shí)證實(shí)伴心動(dòng)過(guò)緩 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at IIb 類和 III 類適應(yīng)證 : 頸動(dòng)脈竇過(guò)敏和神經(jīng)心臟性暈厥的起搏治療 IIb類 : 無(wú) III類 : ， 但無(wú)明顯癥狀或僅有迷走刺激癥狀如頭昏、眩暈 、眩暈或頭昏，但無(wú)頸動(dòng)脈竇刺激引起的高敏心臟抑制反射 ，回避場(chǎng)景刺激暈厥不再發(fā)生 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at Section IG: 兒童、青少年和先天性心臟病患者的起搏治療 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at I 類適應(yīng)證 : 兒童、青少年、 和先天性心臟病的起搏治療 、 心功能不全 或低心排量 ，表現(xiàn)為與年齡不相稱的心動(dòng)過(guò)緩及其癥狀 ，預(yù)計(jì)不能恢復(fù)， 或已持續(xù) 7 天 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at I 類適應(yīng)證 : 兒童 , 青少年 , 和先天性心臟的起搏治療 QRS逸搏心律， 復(fù)雜室性早搏 或心功能不全 ，心室率 5055 bpm ；或合并先天性心臟疾病，心室率 70 bpm VT， 伴或不伴長(zhǎng) QT， 起搏治療被證明有效 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at 1. 慢 快綜合征，需抗心律失常藥長(zhǎng)期治療（除地高辛） 2. 先天性三度房室阻滯 , 1歲以上 , 平均心率 50 bpm； 或突然心室停搏，周長(zhǎng)是基礎(chǔ)心率 2或 3倍， 或有與變時(shí)功能不良相關(guān)的癥狀 3. 長(zhǎng) QT綜合征合并 2:1 二度或三度房室阻滯 . 4. 無(wú)癥狀竇性心動(dòng)過(guò)緩合并復(fù)雜先天性心臟病，靜息時(shí)心率 40 bpm 或有 3 s長(zhǎng)間歇 . 5. 先天性心臟病患者，血液動(dòng)力學(xué)由于心動(dòng)過(guò)緩和房室不同步而受損 . IIa 類適應(yīng)證 : 兒童 , 青少年 , 和先天性心臟的起搏治療 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at 1. 手術(shù)后一過(guò)性三度房室阻滯，恢復(fù)竇律后殘留室內(nèi)雙束支阻滯 2. 先天性三度房室阻滯的 嬰兒和青少年 患者，無(wú)癥狀，其心率可接受，窄 QRS 波，心功能正常 3. 先天性心臟病伴竇性心動(dòng)過(guò)緩，靜息時(shí) HR 40 bpm 或有 3 長(zhǎng)間歇但患者無(wú)癥狀 4. 神經(jīng)肌源性疾病伴發(fā)任何程度 (包括一度 )的房室阻滯，無(wú)論是否有癥狀，因?yàn)閭鲗?dǎo)阻滯隨時(shí)會(huì)加重 IIb 類適應(yīng)證 : 兒童 , 青少年 , 和先天性心臟的起搏治療 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and anti